Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
BRL | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 532 | 466 | 457 | 592 | 563 | 581 | 772 | 1,030 | 1,184 | 1,029 | | 1,029 |
% Growth | NA | -12.5% | -1.8% | 29.4% | -4.9% | 3.3% | 32.7% | 33.4% | 15.0% | -13.1% | | |
| | | | | | | | | | | | |
Cost of Revenue | (379) | (353) | (334) | (460) | (424) | (451) | (587) | (795) | (940) | (806) | | (806) |
Gross Profit | 153 | 113 | 124 | 132 | 139 | 130 | 185 | 235 | 244 | 223 | | 223 |
% Revenue | 28.8% | 24.2% | 27.1% | 22.3% | 24.7% | 22.4% | 24.0% | 22.8% | 20.6% | 21.7% | | 21.7% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (25) | (31) | (27) | (31) | (48) | (42) | (58) | (82) | (79) | (66) | | (66) |
General and Admin | (24) | (26) | (37) | (33) | (35) | (27) | (48) | (54) | (68) | (77) | | (77) |
Other Inc / (Exp) | (1) | (13) | 19 | (1) | (0) | (6) | (18) | 9 | 31 | 92 | | 92 |
Total Operating Exp | (50) | (69) | (45) | (65) | (83) | (75) | (124) | (128) | (116) | (51) | | (51) |
| | | | | | | | | | | | |
Operating Income | 103 | 43 | 79 | 67 | 56 | 55 | 61 | 107 | 127 | 172 | | 172 |
% Revenue | 19.3% | 9.3% | 17.3% | 11.3% | 9.9% | 9.4% | 7.9% | 10.4% | 10.8% | 16.7% | | 16.7% |
| | | | | | | | | | | | |
Interest Expense | 11 | 21 | 14 | 10 | 12 | 15 | 39 | 41 | 55 | (8) | | (8) |
Pre-tax Income | 114 | 65 | 93 | 77 | 68 | 70 | 100 | 149 | 182 | 164 | | 164 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (10) | (11) | (12) | (7) | (13) | (13) | (14) | (23) | (30) | (28) | | (28) |
Net Income to Company | 104 | 54 | 81 | 70 | 55 | 57 | 86 | 126 | 152 | 137 | | 137 |
% Margin | 19.5% | 11.5% | 17.7% | 11.8% | 9.8% | 9.8% | 11.2% | 12.2% | 12.8% | 13.3% | | 13.3% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (1) | (8) | (14) | (19) | (10) | (15) | (3) | (41) | (48) | (65) | | (65) |
Net Income to Stockholders | 102 | 46 | 67 | 51 | 45 | 43 | 83 | 84 | 104 | 71 | | 71 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 102 | 46 | 67 | 51 | 45 | 43 | 83 | 84 | 104 | 71 | | 71 |
% Margin | 19.2% | 9.8% | 14.6% | 8.6% | 8.1% | 7.3% | 10.7% | 8.2% | 8.8% | 6.9% | | 6.9% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 1,022.90 | 0.00 | 0.00 | 0.00 | 0.92 | 0.28 | 0.41 | 0.42 | 0.51 | 0.00 | | 0.00 |
Diluted EPS (Continuing Ops) | 1,022.90 | 0.00 | 0.00 | 0.00 | 0.92 | 0.28 | 0.41 | 0.41 | 0.50 | 0.00 | | 0.00 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 0.10 | 0.00 | 0.00 | 0.00 | 49.48 | 149.69 | 203.73 | 202.18 | 202.57 | 0.00 | | 0.00 |
WA Diluted Shares Out. | 0.10 | 0.00 | 0.00 | 0.00 | 49.48 | 149.69 | 203.73 | 205.15 | 207.99 | 0.00 | | 0.00 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 114 | 65 | 93 | 77 | 68 | 70 | 100 | 149 | 182 | 164 | | 164 |
Addback: Net Interest Expense | (11) | (21) | (14) | (10) | (12) | (15) | (39) | (41) | (55) | 8 | | 8 |
Addback: Other Non Operating Expenses, Total | 0 | (2) | 0 | (3) | 0 | 0 | 0 | (34) | (39) | (106) | | (106) |
Addback: Depreciation & Amortization | 1 | 1 | 1 | 1 | 3 | 3 | 5 | 4 | 5 | 4 | | 4 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 21 | 16 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 104 | 43 | 80 | 64 | 59 | 58 | 76 | 98 | 109 | 70 | | 70 |
% Margin | 19.5% | 9.2% | 17.5% | 10.9% | 10.5% | 9.9% | 9.8% | 9.5% | 9.2% | 6.8% | | 6.8% |
| | | | | | | | | | | | |
Adjusted EBIT | 103 | 42 | 79 | 64 | 56 | 55 | 71 | 94 | 105 | 66 | | 66 |
% Margin | 19.3% | 9.0% | 17.3% | 10.8% | 9.9% | 9.4% | 9.2% | 9.1% | 8.9% | 6.4% | | 6.4% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 104 | 54 | 81 | 70 | 55 | 57 | 86 | 126 | 152 | 137 | | 137 |
Addback: Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 21 | 16 | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | 0 | (0) | 0 | (0) | 0 | 0 | (3) | (5) | (4) | 0 | | 0 |
Adjusted Net Income | 104 | 54 | 81 | 70 | 55 | 57 | 94 | 141 | 164 | 137 | | 137 |
% Margin | 19.5% | 11.6% | 17.7% | 11.8% | 9.8% | 9.8% | 12.2% | 13.7% | 13.8% | 13.3% | | 13.3% |